SGLT2 inhibition may improve CV outcomes in those with diabetes undergoing cancer therapy

Press/Media

Period	14 Jun 2022

Media coverage

Title	SGLT2 inhibition may improve CV outcomes in those with diabetes undergoing cancer therapy
Media name/outlet	Healio
Country/Territory	United States
Date	14/06/22
URL	https://www.healio.com/news/cardiology/20220614/sglt2-inhibition-may-improve-cv-outcomes-in-those-with-diabetes-undergoing-cancer-therapy
Persons	Carlos Gongora